Align Technology, Inc.
ALGN
Rang in Aktien
#1977
Align Technology, Inc. is a medical technology enterprise that develops,... Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
Aktienkurs
$150.24
Marktkapitalisierung
$10.67B
Veränderung (1 Tag)
0.83%
Veränderung (1 Jahr)
11.34%
Land
US
Handel Align Technology, Inc. (ALGN)
Kategorie
Healthcare
KGV für Align Technology, Inc. (ALGN)
KGV zum October 2026 TTM: 25.08
Laut den neuesten Finanzberichten und dem Aktienkurs von Align Technology, Inc. beträgt das aktuelle P/E-Verhältnis (TTM) 25.08. Am Ende des Jahres 2024 hatte das Unternehmen ein P/E von 37.05.
P/E-Verlaufsdaten für Align Technology, Inc. von 2000 bis 2026
P/E-Verhältnis am Ende jedes Jahres
| Jahr | KGV | ändert |
|---|---|---|
| 2026 (TTM) | 25.08 | -9.14% |
| 2025 | 27.60 | -25.50% |
| 2024 | 37.05 | -21.25% |
| 2023 | 47.05 | 3.17% |
| 2022 | 45.61 | -32.11% |
| 2021 | 67.18 | 183.46% |
| 2020 | 23.70 | -52.65% |
| 2019 | 50.05 | 19.47% |
| 2018 | 41.89 | -45.51% |
| 2017 | 76.89 | 89.99% |
| 2016 | 40.47 | 10.64% |
| 2015 | 36.58 | 18.14% |
| 2014 | 30.96 | -56.75% |
| 2013 | 71.59 | 88.02% |
| 2012 | 38.07 | 37.29% |
| 2011 | 27.73 | 38.99% |
| 2010 | 19.95 | -150.67% |
| 2009 | -39.38 | -638.75% |
| 2008 | 7.31 | -76.70% |
| 2007 | 31.37 | -224.12% |
| 2006 | -25.27 | -108.95% |
| 2005 | 282.26 | 283.94% |
| 2004 | 73.52 | -255.13% |
| 2003 | -47.39 | 2,511.46% |
| 2002 | -1.81 | -5.45% |
| 2001 | -1.92 | 81.95% |
| 2000 | -1.05 | 0.00% |
P/E-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/E Ratio | P/E Ratio-Differenz | Land |
|---|---|---|---|
| 33.11 | 32.03% |
US
|
|
| 21.39 | -14.71% |
IE
|
|
| 28.94 | 15.43% |
US
|
|
| 17.34 | -30.86% |
US
|
|
| - | - |
DE
|
Wie liest man ein P/E Ratio?
Das Kurs-Gewinn-Verhältnis (P/E Ratio) misst das Verhältnis zwischen dem Aktienkurs eines Unternehmens und seinem Gewinn pro Aktie.
Ein niedriges, aber positives P/E weist auf ein Unternehmen hin, das hohe Gewinne im Verhältnis zur aktuellen Bewertung erzielt und möglicherweise unterbewertet ist. Ein Unternehmen mit einem hohen negativen (nahe 0) P/E macht hohe Verluste im Verhältnis zur Bewertung.
Unternehmen mit einem P/E über 30 oder negativ werden allgemein als "Wachstumsaktien" betrachtet, was bedeutet, dass Investoren erwarten, dass das Unternehmen in Zukunft wächst oder profitabel wird.
Unternehmen mit einem positiven P/E unter 10 gelten im Allgemeinen als "Value-Aktien", was bedeutet, dass das Unternehmen bereits sehr profitabel ist, aber in Zukunft wahrscheinlich kein starkes Wachstum aufweisen wird.